Cleared Traditional

ORTHOPAEDIC TABLE 1420 (K873273) - FDA 510(k) Clearance

Class I General & Plastic Surgery device.

K873273 · Stierlen-Maquet AG · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1987
Decision
31d
Days
Class 1
Risk

K873273 is an FDA 510(k) clearance for the ORTHOPAEDIC TABLE 1420. Classified as Table, Surgical With Orthopedic Accessories, Manual (product code JEB), Class I - General Controls.

Submitted by Stierlen-Maquet AG (West Germany, GR). The FDA issued a Cleared decision on September 17, 1987 after a review of 31 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4950 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Stierlen-Maquet AG devices

Submission Details

510(k) Number K873273 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 1987
Decision Date September 17, 1987
Days to Decision 31 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 115d · This submission: 31d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JEB Table, Surgical With Orthopedic Accessories, Manual
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4950
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.